Hyderabad: AIG Hospitals unveiled its state-of-the-art NeuroCath Lab on Monday, marking a significant leap in neurovascular care. Equipped with the cutting-edge Philips Azurion 2.2 Biplane system, this facility is set to revolutionize the diagnosis and treatment of strokes and other complex neurovascular conditions.
The lab’s inauguration by Dr. G Chandrashekar Reddy, IFS, Principal Secretary to the Chief Minister, underscores the city’s commitment to advanced healthcare. With India reporting 1.8 million stroke cases annually and a fatality rate exceeding 30%, the need for rapid, efficient treatment has never been greater.
The NeuroCath Lab features advanced 2D and 3D imaging, flexible X-ray detector positioning, and innovative table-side controls that enable precise, minimally invasive procedures. These capabilities are crucial for treating conditions like ischemic strokes, brain aneurysms, and congenital vascular abnormalities, ensuring faster diagnosis and improved patient outcomes.
Speaking at the event, Dr. D Nageshwar Reddy, Chairman of AIG Hospitals, emphasized the urgency of stroke treatment: “Stroke is a medical emergency where every minute counts. This lab enables us to deliver timely and world-class neuro-interventional care, saving lives and preserving quality of life.”
The facility is equipped to perform mechanical thrombectomy, a breakthrough procedure to remove clots in ischemic stroke patients. This intervention, critical within a six-hour window, restores blood flow and minimizes brain damage, offering new hope to patients.Dr. Afshan Jabeen, Director of Neurology at AIG Hospitals, highlighted the transformative impact of the new lab: “Its unparalleled imaging and procedural capabilities allow us to address even the most complex cases effectively. This advancement is a game-changer in neurovascular care.”
The Philips Azurion system includes advanced features like enhanced C-arm rotation, optimal imaging angles, and a specialized head immobilizer for stroke patients. These innovations ensure precision and sterility during procedures, paving the way for better outcomes.
Dr. V K Chaitanya Koduri, Clinical Lead for Stroke and Neurointerventions, summed up the mission: “Time is brain. With this technology and our dedicated team available 24/7, we aim not only to save lives but also to preserve functionality and quality of life for our patients.”
The NeuroCath Lab, supported by a dedicated NeuroICU and round-the-clock stroke specialists, positions Hyderabad as a leader in advanced neurovascular care, offering hope to thousands battling the devastating effects of strokes.
